KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Long-Term Investments (2016 - 2026)

Abbott Laboratories' Long-Term Investments history spans 18 years, with the latest figure at $1.1 billion for Q1 2026.

  • On a quarterly basis, Long-Term Investments rose 20.18% to $1.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 20.18% increase, with the full-year FY2025 number at $918.0 million, up 3.61% from a year prior.
  • Long-Term Investments hit $1.1 billion in Q1 2026 for Abbott Laboratories, up from $918.0 million in the prior quarter.
  • Over the last five years, Long-Term Investments for ABT hit a ceiling of $1.1 billion in Q1 2026 and a floor of $734.0 million in Q2 2022.
  • Historically, Long-Term Investments has averaged $853.3 million across 5 years, with a median of $818.0 million in 2024.
  • Biggest five-year swings in Long-Term Investments: decreased 8.82% in 2022 and later grew 20.18% in 2026.
  • Tracing ABT's Long-Term Investments over 5 years: stood at $766.0 million in 2022, then rose by 4.31% to $799.0 million in 2023, then increased by 10.89% to $886.0 million in 2024, then rose by 3.61% to $918.0 million in 2025, then grew by 18.74% to $1.1 billion in 2026.
  • Business Quant data shows Long-Term Investments for ABT at $1.1 billion in Q1 2026, $918.0 million in Q4 2025, and $951.0 million in Q3 2025.